Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 a » 10 _ (Expand Search), 10 μ (Expand Search), 19 a (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 a » 10 _ (Expand Search), 10 μ (Expand Search), 19 a (Expand Search)
-
121
-
122
-
123
Figure 5 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin
Published 2025“…MFI, mean fluorescence intensity. <b>D,</b> A schematic representation of perforin maturation. …”
-
124
-
125
-
126
Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice.
Published 2019“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”
-
127
-
128
Structure of YOLOv5s-SBC.
Published 2024“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”
-
129
Increasing TPP side chain length decreases melanoma cell viability and clonogenic survival.
Published 2020“…<p>(A) A375 and (B) MeWo melanoma cells were treated with 0.5 μM 5-, 8-, 10-, 12-,14-, or 16-TPP for 24 h, 48 h, or 72 h and analyzed for cell viability by the MTT method (* significant relative to control; p<0.05; N = 4). …”
-
130
-
131
-
132
Downregulation of DOM decreases the abundance of PER and TIM.
Published 2019“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
-
133
-
134
-
135
-
136
B2 decreases glycolytic intermediates in cells.
Published 2025“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
-
137
-
138
-
139
-
140